Catalyst Pharmaceuticals (CPRX) Other Accumulated Expenses (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Other Accumulated Expenses of $745000.0 for Q1 2026, down 11.31% on a QoQ basis from $840000.0 in Q4 2025, and down 66.52% year-over-year from $2.2 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Other Accumulated Expenses history runs 11 years deep, the most recent figure standing at $745000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 66.52% year-over-year to $745000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $745000.0 (down 66.52% YoY) and the FY2025 annual result came in at $840000.0, up 101.44% from the prior year.
- Other Accumulated Expenses was $745000.0 for Q1 2026 at Catalyst Pharmaceuticals, down from $840000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.2 million in Q1 2025 and bottomed at $372000.0 in Q2 2024.
- A 4-year average of $789111.1 and a median of $745000.0 in 2026 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Other Accumulated Expenses soared 101.44% — and 2026, when it sank 66.52%.
- Catalyst Pharmaceuticals' Other Accumulated Expenses stood at $465000.0 in 2023, then fell by 10.32% to $417000.0 in 2024, then surged by 101.44% to $840000.0 in 2025, then declined by 11.31% to $745000.0 in 2026.
- Business Quant data shows CPRX's Other Accumulated Expenses at $745000.0 in Q1 2026, $840000.0 in Q4 2025, and $842000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 745,000.00 |
| Dec 31, 2025 | 840,000.00 |
| Sep 30, 2025 | 842,000.00 |
| Jun 30, 2025 | 747,000.00 |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 417,000.00 |
| Sep 30, 2024 | 449,000.00 |
| Jun 30, 2024 | 372,000.00 |
| Dec 31, 2023 | 465,000.00 |
| Dec 31, 2018 | 66,436.00 |
| Sep 30, 2018 | 38,958.00 |
| Jun 30, 2018 | 4,738.00 |
| Mar 31, 2018 | 19,136.00 |
| Dec 31, 2017 | 24,035.00 |
| Sep 30, 2017 | 12,559.00 |
| Jun 30, 2017 | 2,839.00 |
| Mar 31, 2017 | 7,723.00 |
| Dec 31, 2015 | 17,642.00 |
| Sep 30, 2015 | 21,614.00 |
| Jun 30, 2015 | 77,961.00 |